178 related articles for article (PubMed ID: 21884793)
1. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures.
Gøtzsche CR; Nikitidou L; Sørensen AT; Olesen MV; Sørensen G; Christiansen SH; Ängehagen M; Woldbye DP; Kokaia M
Neurobiol Dis; 2012 Jan; 45(1):288-96. PubMed ID: 21884793
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures.
Woldbye DP; Angehagen M; Gøtzsche CR; Elbrønd-Bek H; Sørensen AT; Christiansen SH; Olesen MV; Nikitidou L; Hansen TV; Kanter-Schlifke I; Kokaia M
Brain; 2010 Sep; 133(9):2778-88. PubMed ID: 20688813
[TBL] [Abstract][Full Text] [Related]
3. Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity.
Olesen MV; Christiansen SH; Gøtzsche CR; Holst B; Kokaia M; Woldbye DP
Neuropeptides; 2012 Apr; 46(2):71-9. PubMed ID: 22342800
[TBL] [Abstract][Full Text] [Related]
4. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
[TBL] [Abstract][Full Text] [Related]
6. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
7. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
Lin EJ; Young D; Baer K; Herzog H; During MJ
Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice.
Elbrønd-Bek H; Olling JD; Gøtzsche CR; Waterfield A; Wörtwein G; Woldbye DP
Synapse; 2014 Oct; 68(10):427-36. PubMed ID: 24985894
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice.
Olesen MV; Christiansen SH; Gøtzsche CR; Nikitidou L; Kokaia M; Woldbye DP
J Neurosci Res; 2012 Feb; 90(2):498-507. PubMed ID: 21971867
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in the neuropeptide Y system during ethanol withdrawal kindling in rats.
Olling JD; Ulrichsen J; Correll M; Woldbye DP
Alcohol Clin Exp Res; 2010 Mar; 34(3):462-70. PubMed ID: 20028355
[TBL] [Abstract][Full Text] [Related]
11. Differential changes in messenger RNA expressions and binding sites of neuropeptide Y Y1, Y2 and Y5 receptors in the hippocampus of an epileptic mutant rat: Noda epileptic rat.
Jinde S; Masui A; Morinobu S; Noda A; Kato N
Neuroscience; 2002; 115(4):1035-45. PubMed ID: 12453477
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y delays hippocampal kindling in the rat.
Reibel S; Benmaamar R; Lê BT; Larmet Y; Kalra SP; Marescaux C; Depaulis A
Hippocampus; 2003; 13(5):557-60. PubMed ID: 12921346
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis.
Kopp J; Nanobashvili A; Kokaia Z; Lindvall O; Hökfelt T
Brain Res Mol Brain Res; 1999 Sep; 72(1):17-29. PubMed ID: 10521595
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.
Silva AP; Xapelli S; Pinheiro PS; Ferreira R; Lourenço J; Cristóvão A; Grouzmann E; Cavadas C; Oliveira CR; Malva JO
J Neurochem; 2005 Apr; 93(1):163-70. PubMed ID: 15773916
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?
Vezzani A; Sperk G
Neuropeptides; 2004 Aug; 38(4):245-52. PubMed ID: 15337376
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y Y5 receptors inhibit kindling acquisition in rats.
Benmaamar R; Richichi C; Gobbi M; Daniels AJ; Beck-Sickinger AG; Vezzani A
Regul Pept; 2005 Feb; 125(1-3):79-83. PubMed ID: 15582717
[TBL] [Abstract][Full Text] [Related]
18. Plastic changes in neuropeptide Y receptor subtypes in experimental models of limbic seizures.
Vezzani A; Moneta D; Mulé F; Ravizza T; Gobbi M; French-Mullen J
Epilepsia; 2000; 41 Suppl 6():S115-21. PubMed ID: 10999532
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin exerts anti-epileptic effects with the suppression of aberrant new cell formation in the dentate gyrus and upregulation of neuropeptide Y in seizure model of rats.
Kondo A; Shingo T; Yasuhara T; Kuramoto S; Kameda M; Kikuchi Y; Matsui T; Miyoshi Y; Agari T; Borlongan CV; Date I
Brain Res; 2009 Nov; 1296():127-36. PubMed ID: 19695235
[TBL] [Abstract][Full Text] [Related]
20. Changes of brain neuropeptide Y and its receptors in rats with flurazepam tolerance and dependence.
Zhang LP; Wang L
Acta Pharmacol Sin; 2005 Nov; 26(11):1290-6. PubMed ID: 16225749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
